1Tsutamoto T, Wada A, Maeda K, et al. Attenuation compensation endogenous cantiac natriuretic peptide system in chronic heart failure:prognostic role of plasma brain natriuretic peptide conomtration in patients with chronic symptomatic left ventricular dysfunction. Circulation, 1997, 96:509-516.
2Chen HH, Burnett JC. Natriuretic peptides in the pathophysiology of congestive heart failure. Curr Cardiol Re,p, 2000, 2:198-205.
3Prahash A, Lyuch T. B - type natriuretic peptide: a diaginostic prognostic and therapeutic tool in heart failure. Am J Crit Care, 2004,13 (1):46-53,54-55.
4Sudoh T, Kanyawa K, Minamino N, et al. A natriuretic peptide in Porcine brain. Nature, 1998,322:78-81.
6Task force for the diagnosis and treatment d chronic heart failure of society d cardiology. Guidelines for the diagnosis and treat-mint of chronic heart failure. Eur Heart J, 2001, 22:1527- 1560.
8Groenning BA, Nilsson JC, Sondergaard L, et al. Evalustion of impaired left ventricular ejection fraction and increased dimensions by multiple neurohumoral plasma concentrations. European Journal of Hearte Failure, 2001, 3:699-708.
9Dickstein K. Natriuretic peptides in detection of heart failure. Lancet, 1998, 35:3-4.
10Michael R. Zile, MD, DirkL, Brutsaert, MD. New Concepts in Diastolic Dysfunction and Diastolic Heart Failure: Part I Diagnosis, Prognoais, and Measurements of Diastolic Function. Circulation, 2002,105:1387.
二级参考文献20
1Ishii J, Nomura M, Nakamura Y, et al. Risk Stratification using a combination of cardiac troponin T and brain natriuretic peptide in patients hospitalized for worsening chronic heart failure. Am J Cardiol,2002, 89 : 691--695.
2Levin ER, Gardner DG, Samson WK. Natriuretic peptides. N Engl J Med, 1998, 339:321--328.
3Troughton RW, Frampton CM, Yandle TG, et al. Treatment of heart failure guided by plasma aminoterminal brain natriuretic peptide (NBNP) concentrations. The Lancet, 2000, 355:1126--1130.
4Hara Y, Hamada M, Shigematsu Y, et al. Effect of Beta-blocker on left ventricular function and natriuretic peptides in patients with chronic heart failure treated with angiotensin-converting enzyme inhibitor.Japanese Circulation Journal, 2000, 64 : 365--369.
5Morita E, Yasue H, Ycxshimura M, et al. Increased plasma levels of brain natriuretic peptide in patients with acute myocardial infarction.Circulation, 1993, 88:82--91.
6Choy AMJ, Darbar D, Lang CC, et al. Detection of left ventricular dysfunction after acut myocardial infarction comparison of clinical,echocardiographic, and neurohormonal methods. Br Heart J, 1994,72 : 16--22.
7Tsutamoto T, Wada A, Maeda K, et al. Plasma brain natriuretic peptide level as a biochemical maker of morbidity and mortality in patients with asymptomatic or minimally symptomatic left ventricular dysfunction. Eur Heart, 1999, 20:1799--1807.
8Clerico A, Lervasi G, Mariani G. Pathophysiologic relevance of measuring the plasma levels of cardiac natriuretic peptide hormones in humans.Horm Metab Res, 1999, 31:487--498.
9Richards AM, Nicholls MG, Yandle TG, et al. Plasma N-terminal pro-brain natriuretic peptide and adrenomedullin: New neurohormonal predictor of left ventricular function and prognosis after myocardial infarction. Circulation, 1998, 97:1921--1929.
10Maisel AS, Koon J, Krishnaswamy P, et al. Utility of B-natriuretic peptide as a rapid, point-of-care test for screening patients undergoing echocardiography to determine left ventricular dysfunction. Am Heart J,2001, 141:367--374.
1Collins SP,Ronan-Bentle S,Storrow AB.Diagnostic and prognostic usefulness of natriuretic peptides in emergency department patients with dyspnea[J].Ann Emerg Med,2003,41:523-545.
2Krishnaswamy P,Lubien E,Clopton P,et al.Utility of B-natriuretic peptide levels in identifying patients with left ventricular systolic or diastoilc dysfunction[J].Am J Med,2001,111:274-279.
3Zaninotto M,Mion M,Altiner S,et al.Nt-proBNP in the differential diaognosis of acute dyspnea in the emergency department[J].Clin Biochem,2005,38(11):1041-1044.
4Cournot M,Leprince P,Destrac S,et al.Usefulness of in-hospital change in B-type natriuretic peptide levels in predicting long-term outcome in elderly patients admitted for decompensated heart failure[J].Am J Geriatr Cardiol,2007,16(1):8-14.
5Maisel AS,Krishnaswamy P,Nowak RM,et al.Rapid measurement of B-type natriuretic peptide in the emergency diagnosis of heart failure[J].N Engl J Med,2002,347:161-167.
6Latini R,Masson S,De Angelis N,et al.Role of brain natriuretic peptide in the diagnosis and management of heart failure:current concepts[J].J Card Fail,2002,8:288-299.
7Chung T,Sindone A,Foo F,et al.Influence of history of heart failure on diagnostic performance and utility of B-type natriuretic peptide testing for acute dyspnea in the emergency department[J].Am Heart J,2006,152(5):949-955.
8Sodian R,Loebe M,Schmitt C,et al.Decreased plasma concentration of brain natriuretic peptide as a potential indicator of cardiac recovery in patients supported by mechanical circulatory assist systems[J].J Am Coll Cardiol,2001,38:1942-1949.
9Doust J,Lehman R,Glasziou P.The role of BNP testing in heart failure[J].Am Fam Physician,2006,7(11):1893-1898.
